Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group.
Koga H, Ozono S, Tsushima T, Tomita K, Horiguchi Y, Usami M, Hirao Y, Akaza H, Naito S; BCG Tokyo Strain Study Group. Koga H, et al. Among authors: ozono s. Int J Urol. 2010 Sep;17(9):759-66. doi: 10.1111/j.1442-2042.2010.02584.x. Epub 2010 Jul 4. Int J Urol. 2010. PMID: 20604814 Clinical Trial.
Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer.
Hinotsu S, Akaza H, Naito S, Ozono S, Sumiyoshi Y, Noguchi S, Yamaguchi A, Nagamori S, Terai A, Nasu Y, Kume H, Tomita Y, Tanaka Y, Samma S, Uemura H, Koga H, Tsushima T. Hinotsu S, et al. Among authors: ozono s. BJU Int. 2011 Jul;108(2):187-95. doi: 10.1111/j.1464-410X.2010.09891.x. Epub 2010 Dec 22. BJU Int. 2011. PMID: 21176079 Clinical Trial.
Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer.
Yokomizo A, Kanimoto Y, Okamura T, Ozono S, Koga H, Iwamura M, Tanaka H, Takahashi S, Tsushima T, Kanayama HO, Akaza H, Shinohara N, Mugiya S, Nomata K, Nakamura T, Naito S. Yokomizo A, et al. Among authors: ozono s. J Urol. 2016 Jan;195(1):41-6. doi: 10.1016/j.juro.2015.08.075. Epub 2015 Aug 22. J Urol. 2016. PMID: 26307162 Clinical Trial.
Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Miki T, Mizutani Y, Akaza H, Ozono S, Tsukamoto T, Terachi T, Naito K, Nonomura N, Hara I, Yoshida O; Japan Blood Cell Transplantation Study Group for Testicular Germ Cell Tumor. Miki T, et al. Among authors: ozono s. Int J Urol. 2007 Jan;14(1):54-9. doi: 10.1111/j.1442-2042.2006.01655.x. Int J Urol. 2007. PMID: 17199861 Clinical Trial.
Risk factors for ipsilateral adrenal involvement in renal cell carcinoma.
Ito K, Nakazawa H, Marumo K, Ozono S, Igarashi T, Shinohara N, Fukuda M, Tsushima T, Naito S, Hayakawa M; Japanese Society of Renal Cancer. Ito K, et al. Among authors: ozono s. Urology. 2008 Aug;72(2):354-8. doi: 10.1016/j.urology.2008.02.035. Epub 2008 May 12. Urology. 2008. PMID: 18468657
434 results